Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFRT790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
- Resource Type
- Article
- Source
- Journal of Thoracic Oncology; 20210101, Issue: Preprints
- Subject
- Language
- ISSN
- 15560864; 15561380